Zwijnaarde, Belgium

Mycartis N.v.

Calculating rank
USPTO Granted Patents = 17

% Expired Patents = 100.0



Forward Citations = 82

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Nicolas Demierre (9 out of 9 patents)

silverMedal Raphael Tornay (6 out of 6 patents)

bronzeMedal Koen Kas (5 out of 14 patents)

4.  Philippe Renaud (4 out of 35 patents)

5.  Stephan Gamper (4 out of 4 patents)

6.  Didier Falconnet (3 out of 3 patents)

7.  Joseph Demeester (2 out of 7 patents)

8.  José Gil (2 out of 2 patents)

9.  Piet Moerman (2 out of 3 patents)

10.  Stefaan Cornelis De Smedt (2 out of 2 patents)

11.  Christiaan Hubert Simon Roelant (2 out of 5 patents)

12.  Rudi Wilfried Jan Pauwels (2 out of 4 patents)

13.  Griet Vanpoucke (2 out of 5 patents)

14.  David Rebetez (1 out of 1 patent)

15.  David Bernasconi (1 out of 1 patent)


17 patents:

Company Overview
Mycartis N.V. is a biotechnology company based in Zwijnaarde, Belgium, specializing in the development of innovative diagnostic solutions. The organization focuses on personalized medicine, particularly in the fields of oncology and infectious diseases, leveraging advanced technologies to enhance patient care. Mycartis aims to provide healthcare professionals with precise tools for patient stratification and treatment optimization, contributing to the evolving landscape of targeted therapies and diagnostics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

17 Patents

#5 in Zwijnaarde

#181 in Belgium

#35,974 in the World

Zwijnaarde, BE
Zwijnaarde, Belgium
Forward Citations = 82

21 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mycartis N.v.. Retrieved from https://idiyas.com/company/mycartis-n-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…